| Literature DB >> 29961843 |
Veronika L Tchesnokova1, Elena Rechkina2, Lydia Larson1, Kendra Ferrier1, Jamie Lee Weaver1, David W Schroeder1, Rosemary She3, Susan M Butler-Wu3, Maria E Aguero-Rosenfeld4, Danielle Zerr5, Ferric C Fang6, James Ralston7,8, Kim Riddell7, Delia Scholes7,8, Scott Weissman5, Kaveri Parker2, Brad Spellberg3, James R Johnson9, Evgeni V Sokurenko1.
Abstract
We describe the rapid and ongoing emergence across multiple US cities of a new multidrug-resistant Escherichia coli clone-sequence type (ST) 1193-resistant to fluoroquinolones (100%), trimethoprim-sulfamethoxazole (55%), and tetracycline (53%). ST1193 is associated with younger adults (age <40 years) and currently comprises a quarter of fluoroquinolone-resistant clinical E. coli urine isolates.Entities:
Mesh:
Year: 2019 PMID: 29961843 PMCID: PMC6321845 DOI: 10.1093/cid/ciy525
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079